| (a) Stock, dispensing and unit-dose containers. A stock
bottle, dispensing bottle, vial, or ampule (not to exceed 1 liter
or 10,000 pills); or a unit-dose container (e.g., a unit-dose packet,
cup, wrapper, blister pack, or delivery device) is considered empty
and the residues are not regulated as hazardous waste provided the
pharmaceuticals have been removed from the stock bottle, dispensing
bottle, vial, ampule, or the unit-dose container using the practices
commonly employed to remove materials from that type of container.
(b) Syringes. A syringe is considered empty and the
residues are not regulated as hazardous waste under this subchapter
provided the contents have been removed by fully depressing the plunger
of the syringe. If a syringe is not empty, the syringe must be placed
with its remaining hazardous waste pharmaceuticals into a container
that is managed and disposed of as a non-creditable hazardous waste
pharmaceutical under this subchapter and any applicable federal, state,
and local requirements for sharps containers and medical waste.
(c) Intravenous (IV) bags. An IV bag is considered
empty and the residues are not regulated as hazardous waste provided
the pharmaceuticals in the IV bag have been fully administered to
a patient. If an IV bag is not empty, the IV bag must be placed with
its remaining hazardous waste pharmaceuticals into a container that
is managed and disposed of as a non-creditable hazardous waste pharmaceutical
under this subchapter, unless the IV bag held non-acute hazardous
waste pharmaceuticals and is empty as described in §335.41(f)
of this title (relating to Purpose, Scope, and Applicability).
(d) Other containers, including delivery devices. Hazardous
waste pharmaceuticals remaining in all other types of unused, partially
administered, or fully administered containers must be managed as
non-creditable hazardous waste pharmaceuticals under this subchapter,
unless the container held non-acute hazardous waste pharmaceuticals
and is empty as described in §335.41(f) of this title. This includes,
but is not limited to, residues in inhalers, aerosol cans, nebulizers,
tubes of ointments, gels, or creams.
|
